News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Asklepios BioPharmaceutical, Inc. Enters Cross-License Agreement With Genzyme Corporation (GENZ)



7/16/2013 10:03:51 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

CHAPEL HILL, N.C.--(BUSINESS WIRE)--Asklepios BioPharmaceutical, Inc. (AskBio) today announced that it has entered into a non-exclusive cross-license agreement with Genzyme, a Sanofi company, in which Genzyme receives rights to AskBio’s Duplex gene therapy vector technology for its internal product development and external sublicensing.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES